Japan in-vitro diagnostics market was valued at USD 6.2 billion in 2024 and is expected to grow to USD 12.6 billion by 2037, reflecting a compound annual growth rate (CAGR) of 5.6% over the forecast period from 2025 to 2037. By 2025, the market size is projected to reach USD 6.5 billion. The in-vitro diagnostics (IVD) market in Japan is witnessing sustained growth, driven by a growing elderly population, increasing incidence of chronic diseases, and heightened awareness of preventive care. With over 28% of the population aged 65 and older, demand for routine diagnostics and molecular testing is surging across hospitals and diagnostic labs. Innovations in point-of-care testing, real-time PCR, and lab automation are transforming clinical workflows and improving patient outcomes.
Table of Contents
- Japan In-vitro Diagnostics Market
- An Outline of the Japan In-vitro Diagnostics Market
- Market Definition and Segmentation
- Study Assumptions and Abbreviations
- Research Methodology & Approach
- Primary Research
- Secondary Research
- SPSS Methodology
- Data Triangulation
- Executive Summary
- Competitive Landscape
- Competitive Intelligence
- Outcome: Actionable Insights
- Global Industry Overview
- Industry Supply Chain Analysis
- DROT
- Driver
- Restraint
- Opportunities
- Trends
- Government Regulation
- Competitive Landscape
- Canon Medical Systems
- Fujirebio Holdings, Inc.
- Hitachi High-Tech Corporation
- Nipro Corporation
- Shimadzu Scientific Instruments
- Sysmex Corporation
- Japan Overview
- Market Value (USD Million), Current and Future Projections, 2019-2037
- Increment $ Opportunity Assessment, 2019-2037
- Japan Segmentation (USD Million), 2019-2037, By Product Type, Value (USD Million)
- Instruments
- Reagents & Kits
- Software
- Services
- Technology, Value (USD Million)
- Clinical Chemistry
- Hematology
- Immunoassay
- Microbiology
- Molecular Diagnostics
- Others
- Application, Value (USD Million)
- Cardiology
- Gastroenterology
- Infectious Diseases
- Oncology
- Others
- End user, Value (USD Million)
- Hospitals
- Diagnostic Centers
- Home Care Settings
- Research Institutes
- About the Publisher
Companies Mentioned
- Sysmex Corporation
- Roche Diagnostics K.K.
- Abbott Japan Co. Ltd.
- Fujirebio Inc.
- Arkray Inc.
- Beckman Coulter K.K.
- Miraca Holdings Inc.
- LSI Medience Corporation
- Ortho Clinical Diagnostics Japan
- bioMérieux Japan Ltd.
- Becton Dickinson (BD) Japan
- Agilent Technologies Japan
- Sekisui Medical Co. Ltd.
- Eiken Chemical Co. Ltd.
- Nihon Kohden Corporation
